Mr
Christian
Himmler

Patent Director

Munich Office Salzburg Office

Engineering

Telephone. +49(0) 891 259 9600
Email. [email protected]

Experience

Christian has considerable experience in drafting and prosecuting patent applications in the fields of mechanical engineering, medical engineering and renewable energies. Practice areas include fuel cells, medical devices, utility engineering, automotive and aerospace technologies. Furthermore he deals with opposition and appeal procedures.

Christian is a fully qualified European Patent Attorney (EPA), with experience in the in the field of industrial property rights since 2006. In that time, Christian has been involved in all aspects of patent law practice, including the preparation (drafting) and prosecution of German, European, International (PCT) and overseas patent applications, as well as post-grant issues such as opposition and appeal proceedings and develops patent strategies for clients. Christian also handles non-European patent prosecution especially in USA, China, Japan, Australia and Canada.

His experience covers a variety of subject-matter in preparing patent applications and the corresponding granting process in the fields of mechanical engineering, aeronautical engineering, automotive engineering, utility engineering, medical engineering and renewable energies.

Christian earned his mechanical engineering degree at the Munich University of Applied Sciences. During his studies, he completed a first internship at a company involved in the aerospace industry, where he dealt with engines and valves for rockets. A second internship in the field of regenerative energies involved the development of fuel cells. He gained further experience as part of an internship in the automotive industry, and as a student trainee at a company that certified automotive components and at a company that was active in the field of fuel cell development.

Qualifications

Patent Attorney

Europe


DIPL.-ING

(FH)

OTHER

Dipl. -Ing (FH) Maschinenbau

Publications

From March 1 Patronus IP have merged with HGF

View publication online

Related News

From Theoretical Proposals to Commercial Reality: The Rise of Innovation and Patent Filings in Quantum Computing

The possibility of quantum computing was first seriously proposed in the early 1980s and is widely regarded as having enormous potential to deliver a step change in the complexity of …

Read article
Event - 3rd February 2023

The European Patent Office are running an inspiring collaborative art competition for children

To celebrate the 50th anniversary of the signing of the European Patent Convention, The European Patent Office (EPO) is running a collaborative art competition for primary schools on the topic …

Event details
Event - 8th-9th February 2023

5th Annual Microbiome & Probiotic Conference 2023

The 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference will take place in San Diego on the 8th-9th of February. This conference will enable you to learn about microbial …

Event details
Event - 17th January 2023

CIPA Webinar: Enhancing Diversity in the Patent Profession How Can I Help

CIPA hosted a webinar to discuss ‘Enhancing diversity in the patent profession.’ Date Tuesday 17 January, 2023 Time 12.30pm – 1.30pm (GMT) Equity, diversity and inclusion has been in the …

Event details

LiDAR: A Significant Support Technology at CES

When visiting CES’ one thing that struck me was the number of companies demonstrating LiDAR technology. LiDAR has been around since the 1960s and was originally developed for aerospace use, …

Read article

Healthcare and Climate Change

Can we find a balance between intellectual property rights and public health needs when tackling the climate crisis? “The world faces a critical juncture. A health-centred, aligned response to the …

Read article

Navigating the CRISPR IP confusion

It is just over 10 years since the Science publication of Jinek et al. showed for the first time that DNA cleavage could be achieved in vitro with a Cas9 …

Read article

CRISPR Edited T cells win the TvT Battle

T-cells which have been modified using CRISPR base editing technology have been successfully used to treat T-cell acute lymphoblastic leukaemia for the first time {1}. A 13 year old patient …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.